Filing Details

Accession Number:
0000912282-25-000176
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-19 21:16:08
Reporting Period:
2024-06-25
Filing Date:
2025-02-19
Accepted Time:
2025-02-19 21:16:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1509261 Rezolute Inc. RZLT Pharmaceutical Preparations (2834) 273440894
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1768406 Young-Jin Kim C/O Rezolute, Inc.
275 Shoreline Drive, Suite 500
Redwood City CA 94065
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2025-02-16 25,500 $0.00 140,950 No 4 A Direct
Common Shares Acquisiton 2024-06-25 1,250,000 $4.00 7,192,617 No 4 P Indirect Held by Handok, Inc.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 P Indirect Held by Handok, Inc.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Director Stock Option (Right to Buy) Acquisiton 2025-02-16 15,000 $0.00 15,000 $4.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,000 2035-02-16 No 4 A Direct
Footnotes
  1. Represents grant of restricted stock units which vest 100% on March 1, 2026.
  2. The reporting person disclaims beneficial ownership of the securities held by Handok, Inc., except to the extent of his pecuniary interest therein, if any.
  3. The options vest 100% on March 1, 2026.